TC BioPharm (Holdings) PLC (TCBP)
0.61
-0.02
(-3.14%)
USD |
NASDAQ |
Nov 22, 13:16
TC BioPharm Total Assets (Quarterly): 9.171M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.171M |
| June 30, 2023 | 10.38M |
| December 31, 2022 | 13.67M |
| June 30, 2022 | 16.46M |
| Date | Value |
|---|---|
| December 31, 2021 | 10.83M |
| September 30, 2021 | 9.585M |
| December 31, 2020 | 9.903M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.171M
Minimum
Mar 2024
16.46M
Maximum
Jun 2022
11.43M
Average
10.38M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 317.44M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 381.82M |
| NuCana PLC | 25.38M |
| Autolus Therapeutics PLC | 827.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.807M |
| Shareholders Equity (Quarterly) | 1.364M |